Childhood Apraxia of Speech
13
4
8
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (13)
Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial.
Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect
Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech
Role of Omega-DEK in Childhood Apraxia of Speech
Rapid Syllable Transition (ReST) Interventions for Speech Sound Disorders in Children
A Randomized Control Trial of Motor-based Intervention for CAS
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
ASSIST: Treatment for Childhood Apraxia of Speech
Methylphenidate in Childhood Apraxia of Speech
Dose Frequency RCT on DTTC in Children With CAS
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
Childhood Apraxia of Speech: Experience Dependent Changes Induced by Treatment
Treating Childhood Apraxia of Speech